August 15, 2017
Using fragments of circulating tumor DNA in blood, University of California San Diego School of Medicine researchers were able to identify theoretically targetable genetic alterations in 66 percent of patients with cancer of unknown primary (CUP), a rare disease with seven to 12 cases per 100,000 people each year.
March 23, 2022
A team led by engineers at the University of California San Diego has developed a device that is a first step to enabling noninvasive, ultrasound-based therapies for the brain. For example, ultrasound waves are currently being used in clinical trials to treat epilepsy.
March 5, 2018
A team of researchers has developed a light-activated switch that can turn genes on and off in mammalian cells. This is the most efficient so-called “optogenetic switch” activated by red and far-red light that has been successfully designed and tested in animal cells—and it doesn’t require the addition of sensing…
March 9, 2021
Researchers at University of California San Diego School of Medicine and Moores Cancer Center demonstrated that a new tumor-penetrating therapy could enhance the effects of chemotherapy, reduce the spread of pancreatic cancer and increase survival in animal models.
March 13, 2012
Tracking the genetic pathway of a disease offers a powerful, new approach to drug discovery, according to scientists at the University of California, San Diego School of Medicine who used the approach to uncover a potential treatment for prostate cancer, using a drug currently marketed for congestive heart failure.
February 22, 2022
UC San Diego School of Medicine, Weill Cornell Medicine and Stanford Medicine have launched a three-year study to investigate new ways to treat or prevent major depression, accelerate effective treatments and develop predictive models to identify which treatments work best for individual patients.
November 28, 2023
The University of California San Diego announced the recipients of the 2023 Chancellor’s Medal and the Lifetime Legacy Award, who have all helped advance health care and medicine in unique, impactful ways.
January 30, 2023
A new biomaterial that can be injected intravenously, reduces inflammation in tissue and promotes cell and tissue repair. The biomaterial was tested and proven effective in treating tissue damage caused by heart attacks in both rodent and large animal models.
August 12, 2014
Oncologists at UC San Diego Moores Cancer Center are the first in San Diego to meld MRI technology with a traditional ultrasound prostate exam to create a three-dimensional map of the prostate that allows physicians to view growths that were previously undetectable.
October 23, 2014
…Weapon Against Deadly New Target Developed at UC San Diego more than a decade ago, brincidofovir takes on Ebola With the Ebola crisis ongoing, much attention is focused upon finding a drug capable of slowing – if not stopping – the infectious, deadly and terrifying virus. UC Health System Forms…
